Background: Atrial fibrillation (AF) is the most common arrhythmia that affects 33.5 million people worldwide. AF is a $6 billion dollars economic burden and contributes to 700,000 hospital admissions annually to the United States. AF leads to the development of strokes and thrombo-embolic events. The risk of stroke increases five times with AF. Some 75% of these strokes lead to severe disability and death. These strokes are 68% preventable with anticoagulants.
However, evidence indicates that anticoagulants are underused in 83% of AF patients. Provider education is would to improve anticoagulation usage in AF.
Objective: This is a quality improvement project to provide CHA2DS2-VASc and HAS-BLED education to hospital providers. The purpose is to improving appropriate anticoagulation ordering in atrial fibrillation, increase safety and improve patient outcomes.
Design: A quality improvement project using a quantitative descriptive design with a post program evaluation after educational video.
Intervention: A 10-minute educational video on CHA2DS2-VASc and HAS-BLED delivered electronically. The education includes indication for using the CHA2DS2-VASc/HAS-BLED scales and anticoagulation decision-making
Measurements: Self-reported knowledge gains and clinical practice changes after educational intervention on CHA2DS2-VASc/HAS-BLED using a Likert Scale via the Qualtrics platform.
Setting: Yavapai Regional Medical Center in Prescott, Arizona.
Participants: A total of 14 out of 36 providers of the Northern Arizona Hospitalist group participated in this quality improvement project.
Results: The majority of participants of this quality improvement project self-reported knowledge enhancement on CHA2DS2-VASC (92.7%) and HASBLED (92.7%). Similarly, the majority of participants reported planned clinical practice changes based on CHA2DS2-VASC (85.7%) and HAS-BLED (78.6%). The majority of participants in this project reported intended clinical practice changes by evaluating risk stroke in atrial fibrillation with CHA2DS2-VASC (100%) and HAS-BLED (85.7%).
Conclusions: This project showed CHA2DS2-VASc/HASBLED education to enhance knowledge of the risk evaluation scales and self-reported future changes in clinical practice changes due to the activities of this project in the majority of providers.
|Advisor:||Carlisle, Heather l, Trinidad, David R|
|Commitee:||Martin Plank, Lorraine M|
|School:||The University of Arizona|
|School Location:||United States -- Arizona|
|Source:||DAI-B 81/11(E), Dissertation Abstracts International|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be